Clinical and Laboratory Predictors of Respiratory Morbidities in CP Children

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Recurrent Respiratory Tract Infections Clinical Trial

Official title:
Clinical and Laboratory Predictors of Respiratory Morbidities in Children With Cerebral Palsy at Assiut University Children Hospital

Status Not yet recruiting

Clinical Trial Summary

Relationship between respiratory morbidities and cerebral palsy in children

Identification of symptoms,signs,severity and outcomes of respiratory morbidities in children with Cp ;

See also
Status	Clinical Trial	Phase
Completed	`NCT02617771` - Impact of Vitamin D Supplementation on Recurrent Respiratory Infections in Paediatric Primary Care.	Phase 4
Terminated	`NCT04408443` - Evaluation of Lactobacillus Reuteri DSM 17938 + Vitamin D3 in the Prevention of RRI in Paediatric Patients	N/A
Recruiting	`NCT05684848` - Evaluate the Effect of Nasal Spray in the Prevention of RTI in Children With Pre-school Wheezing	N/A
Recruiting	`NCT06201494` - Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents
Completed	`NCT04322669` - Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI)	Phase 4